## Core Concept
Blinding in clinical trials is a method used to reduce bias. It involves concealing the group assignments from the participants, researchers, or outcome assessors to prevent any influence on the results. The primary goal is to minimize **observer bias** and **performance bias**.

## Why the Correct Answer is Right
The correct answer, , refers to **observer bias** or more broadly, **detection bias**. This type of bias occurs when the researcher or participant's knowledge of the group assignment influences the measurement of outcomes. Blinding helps to eliminate this bias by ensuring that the assessment of outcomes is done objectively, without the influence of group assignment knowledge.

## Why Each Wrong Option is Incorrect
* **Option A:** - This option is incorrect because while related, it does not directly specify the type of bias that blinding primarily aims to eliminate.
* **Option B:** - This option is incorrect because, although important, blinding does not directly address **selection bias**, which occurs during the recruitment phase.
* **Option C:** - This option is incorrect as it does not relate to a commonly classified type of bias in the context of blinding.
* **Option D:** - This option is incorrect because **attrition bias** (or drop-out bias) occurs when there is a difference in the loss of participants from the study between groups, which blinding does not directly eliminate.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **blinding can be single (one party is blinded), double (two parties are blinded), or triple (all three parties - participants, researchers, and outcome assessors - are blinded)**. The level of blinding impacts the risk of bias in a study.

## Correct Answer: D. Detection bias.